[REVISION HISTORY]

Respiratory virus vaccination guidance and developments

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-09-06 22:32 UTC → 2026-09-10 00:31 UTC · added ~~removed~~

Health experts and medical organizations are emphasizing the importance of vaccination as the respiratory virus season approaches. Initial reports highlighted the impact of the 2024-25 U.S. flu season, which resulted in approximately 51 million illnesses and 45,000 deaths, while noting technological advancements such as the FDA approval of Moderna’s mFLUSIVA, an mRNA flu vaccine for adults aged 50 and older. As the season progresses, the focus has expanded to include a resurgence of influenza, COVID-19, and Respiratory Syncytial Virus (RSV). The FDA has approved updated COVID-19 vaccines, and major medical organizations are providing guidance following changes to federal recommendations. Medical professionals continue to stress that vulnerable populations—including the elderly, young children, pregnant individuals, and those with chronic conditions—remain at the highest risk for severe complications like pneumonia. With autumn approaching, medical experts are refining guidance on vaccination schedules. Pathologist Giorgos Pappas suggests that the current period is an ideal time for RSV vaccinations, specifically for individuals over 75 and those aged 60-75 with underlying health conditions, noting that protection from previous doses often lasts. For influenza and COVID-19, experts recommend waiting until late September or early October for the availability of updated vaccines, with enhanced flu shots recommended for those over 65. Due to overlapping symptoms such as fever, cough, and fatigue, Dr. Daniel Allan advises that testing is the “only definitive way to distinguish COVID-19 from the flu.” To manage symptoms, experts recommend rest and high levels of hydration using water or electrolytes while avoiding sugary or caffeinated drinks. More recently, physicians have issued urgent calls for influenza vaccinations to protect children, who face significant risks of serious illness and hospitalization. Data from the American Academy of Pediatrics (AAP) indicates that vaccination can reduce the risk of flu-related death in children and teens by approximately 80%.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.